These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27898361)

  • 21. [Involuntary movements caused by thalamic lesion].
    Moroo I; Hirayama K; Kojima S
    Rinsho Shinkeigaku; 1994 Aug; 34(8):805-11. PubMed ID: 7994988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy Endorsed by Vascular European Reference Network (VASCERN).
    Bersano A; Khan N; Fuentes B; Acerbi F; Canavero I; Tournier-Lasserve E; Vajcoczy P; Zedde ML; Hussain S; Lémeret S; Kraemer M; Herve D
    Eur Stroke J; 2023 Mar; 8(1):55-84. PubMed ID: 37021176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalassemia and Moyamoya Syndrome: Epidemiology and long-term outcome.
    Das S; Ray BK; Pandit A; Ghosh R; Chakraborty AP; Dubey S
    Eur J Paediatr Neurol; 2022 Nov; 41():63-70. PubMed ID: 36368232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of moyamoya-like disease with repetitive TIA on drinking].
    Ohkawa S; Tabuchi M; Yamadori A
    Rinsho Shinkeigaku; 1992 Jul; 32(7):758-62. PubMed ID: 1291172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moyamoya disease in children.
    Takanashi J
    Brain Dev; 2011 Mar; 33(3):229-34. PubMed ID: 20932697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Movement disorders associated with moyamoya disease: a report of 4 new cases and a review of literatures.
    Baik JS; Lee MS
    Mov Disord; 2010 Jul; 25(10):1482-6. PubMed ID: 20629162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.
    Fujimura M; Kaneta T; Mugikura S; Shimizu H; Tominaga T
    Surg Neurol; 2007 Mar; 67(3):273-82. PubMed ID: 17320638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term mortality in patients with moyamoya angiopathy according to stroke presentation type in South Korea.
    Im SH; Jang DK; Kim H; Park SK; Han KD
    Acta Neurochir (Wien); 2021 Dec; 163(12):3473-3481. PubMed ID: 34427768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
    Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
    J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Symptomatology of movement disorders in children].
    Czochanska J
    Med Wieku Rozwoj; 2001; 5(2):173-8. PubMed ID: 11679682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence, clinical features, and treatment of familial moyamoya in pediatric patients: a single-institution series.
    Gaillard J; Klein J; Duran D; Storey A; Scott RM; Kahle K; Smith ER
    J Neurosurg Pediatr; 2017 May; 19(5):553-559. PubMed ID: 28291427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moyamoya-induced paroxysmal dyskinesia.
    Gonzalez-Alegre P; Ammache Z; Davis PH; Rodnitzky RL
    Mov Disord; 2003 Sep; 18(9):1051-6. PubMed ID: 14502675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology of Moyamoya Angiopathy in Eastern India.
    Das S; Dubey S; Das S; Hazra A; Pandit A; Ghosh R; Ray BK
    Front Neurol; 2022; 13():837704. PubMed ID: 35309562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unilaterally symptomatic moyamoya disease in children: long-term follow-up of 20 patients.
    Nagata S; Matsushima T; Morioka T; Matsukado K; Mihara F; Sasaki T; Fukui M
    Neurosurgery; 2006 Oct; 59(4):830-6; discussion 836-7. PubMed ID: 17038947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repetitive involuntary movement associated with episodic cerebral ischemia.
    Yanagihara T; Piepgras DG; Klass DW
    Ann Neurol; 1985 Aug; 18(2):244-50. PubMed ID: 3929672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Volitional control of involuntary movements.
    Koller WC; Biary NM
    Mov Disord; 1989; 4(2):153-6. PubMed ID: 2733707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sydenham's chorea as a presentation of Moyamoya disease.
    Cardenas JF; Chapman K
    Semin Pediatr Neurol; 2010 Mar; 17(1):30-4. PubMed ID: 20434690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spontaneous abnormal involuntary movements in first-episode schizophrenia and schizophreniform disorder: baseline rate in a group of patients from an Irish catchment area.
    Gervin M; Browne S; Lane A; Clarke M; Waddington JL; Larkin C; O'Callaghan E
    Am J Psychiatry; 1998 Sep; 155(9):1202-6. PubMed ID: 9734543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.